What Happened
James Poole, an EMT with Mercy Medical Center's EMS operations in Carthage and Mount Vernon, Missouri, tampered with fentanyl and hydromorphone vials stocked on ambulances and in office supply.
Paramedics first noticed puncture marks on a fentanyl vial being used to treat a patient, then a second incident where a syringe drawn from a vial did not have enough fluid for a full dose. A review of ambulance and office stock at the Carthage and sister Mount Vernon facilities found fentanyl and hydromorphone vials with visible signs of tampering; lab testing at Mercy Medical Center in Springfield confirmed 26 fentanyl and 43 hydromorphone vials had some of their original contents replaced with saline or water. Supervisors drug-tested staff the day the tampering was discovered, and Poole tested positive for norfentanyl, a fentanyl metabolite.
Poole admitted he was an opioid addict following an ambulance-accident injury in December 2018, and that he had tampered with and stolen fentanyl on an EMS call three weeks before he was caught — documenting that he gave a patient with abdominal pain 100 mcg of fentanyl while actually administering only 50 mcg, then injecting the stolen remainder into himself after his shift. He pleaded guilty on September 17, 2020, to tampering with a consumer product.
What Went Wrong
Widescale tampering across two ambulance facilities went undetected until frontline paramedics happened to notice physical signs on the vials. Key failures included:
- No routine inspection or potency testing of narcotics kits restocked on ambulances allowed dozens of tampered vials to remain in active use.
- Documented administration amounts were not reconciled against actual patient-reported relief or vital signs, allowing under-dosing to go unnoticed.
- A single EMT had unsupervised access to restock and handle controlled substances across two sister ambulance locations.
- No fitness-for-duty or impairment screening flagged an employee recovering from a workplace injury as higher-risk for diversion.
How It Could Have Been Prevented
- Require physical inspection and periodic potency testing of narcotics vials restocked on ambulances at each shift change.
- Reconcile documented administered doses against patient outcomes and call records to catch systematic under-dosing.
- Require two-person verification when restocking or accessing narcotics kits shared across multiple ambulance locations.
- Implement post-injury and periodic fitness-for-duty screening for EMS staff with controlled substance access.
- Run random drug testing programs for EMS personnel independent of a triggering incident.
Related Guidance
- Tough Issues — High-risk scenarios with annotated SQL for analyzing dispense-to-administer gaps.
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators including documentation irregularities.
- Diversion prevention checklist — Self-assessment for ambulance and field narcotics controls.
- Employee Screening & Fitness for Duty — DEA screening requirements (21 C.F.R. §1301.90) for staff with controlled substance access.